← Leaderboards
Audra L Stinchcomb
University Of Kentucky
$9,682,621
Attributed
$14,626,747
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$9,576,757 · 8
FDA$5,049,990 · 2
By mechanism
U01$5,049,990 · 2
RC2$4,013,265 · 1
R01$3,484,609 · 2
R42$1,233,772 · 1
R21$433,769 · 1
R43$275,525 · 2
Top collaborators
- Annette L Bunge5 shared
- M. Begona Delgado-Charro5 shared
- Richard H Guy5 shared
- Hazem E. Hassan4 shared
- Stephen W. Hoag3 shared
- Lynn Webster2 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Sharon L. Walsh$101,480,172
- Craig R Rush$27,535,139
- Stefan Stamm$4,137,369
- Kalpana Paudel$15,183
Others in their field
Top investigators on “Skin”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,104,269
- Donald Ym Leung · University Of Colorado Denver$58,473,424
- Thomas S. Kupper · Dana-Farber Cancer Institute$53,329,207
- Elaine Fuchs · University Of Chicago$41,573,105
- Timothy Burgess · National Institute Of Allergy And Infectious Diseases$35,600,000
- David Leung · National Jewish Health$31,859,607
Research focus
SkinNaltrexoneProdrugsDiffusionAdverse EffectsPharmaceutical PreparationsPropertyIn VitroUnited StatesDoseOralSolubilitySolventsPlasmaDrug Delivery SystemsDrug AddictionDesignCravingDosage FormsDrug KineticsIn VivoMolecular WeightOpioidAlcohol Abuse
Grant awards (33)
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,999
U01 · FY2017 · FD · contact PI
Heat Effect on Generic Transdermal Drug Delivery Systems$499,999
U01 · FY2017 · FD · contact PI
Heat Effect on Generic Transdermal Drug Delivery Systems$499,999
U01 · FY2016 · FD · contact PI
Bioequivalence of topical drug products: in vitro - in vivo correlations$350,000
U01 · FY2016 · FD · contact PI
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,999
U01 · FY2015 · FD · contact PI
Heat Effect on Generic Transdermal Drug Delivery Systems$499,999
U01 · FY2015 · FD · contact PI
Heat Effect on Generic Transdermal Drug Delivery Systems$700,000
U01 · FY2014 · FD · contact PI
Transdermal Naltrexone for Opiate Addiction and Alcoholism$695,993
R42 · FY2014 · DA · contact PI
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,998
U01 · FY2014 · FD · contact PI
Heat Effect on Generic Transdermal Drug Delivery Systems$499,999
U01 · FY2013 · FD · contact PI
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,998
U01 · FY2013 · FD · contact PI
Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi$230,144
R21 · FY2013 · DA · contact PI
Transdermal Naltrexone for Opiate Addiction and Alcoholism$537,779
R42 · FY2012 · DA · contact PI
Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi$203,625
R21 · FY2012 · DA · contact PI
Transdermal delivery of 2-Arachidonoyl glycerol (2-AG) for the treatment of arthr$76,750
R03 · FY2012 · DA · contact PI
Transdermal Cannabidiol Prodrug Delivery$160,500
R43 · FY2011 · DA · contact PI
Transdermal delivery of 2-Arachidonoyl glycerol (2-AG) for the treatment of arthr$59,067
R03 · FY2011 · DA · contact PI
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence$1,932,519
RC2 · FY2010 · DA · contact PI
Naltrexone Prodrugs for Transdermal Delivery$280,002
R01 · FY2010 · DA · contact PI
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence$2,080,746
RC2 · FY2009 · DA · contact PI
Naltrexone Prodrugs for Transdermal Delivery$310,666
R01 · FY2009 · DA · contact PI
Transdermal Delivery of Buprenorphine Prodrugs$115,025
R43 · FY2009 · DA · contact PI
Naltrexone Prodrugs for Transdermal Delivery$282,831
R01 · FY2008 · DA · contact PI
Naltrexone Prodrugs for Transdermal Delivery$27,835
R01 · FY2008 · DA · contact PI
Naltrexone Prodrugs for Transdermal Delivery$299,065
R01 · FY2007 · DA · contact PI
Transdermal Codrugs for Treatment of Alcoholism$359,596
R01 · FY2006 · AA · contact PI
Transdermal Codrugs for Treatment of Alcoholism$368,250
R01 · FY2005 · AA
Transdermal Codrugs for Treatment of Alcoholism$368,000
R01 · FY2004 · AA
Naltrexone Prodrugs for Transdermal Delivery$253,400
R01 · FY2004 · DA
Naltrexone Prodrugs for Transdermal Delivery$61,498
R01 · FY2004 · DA
Transdermal Codrugs for Treatment of Alcoholism$366,666
R01 · FY2003 · AA
Naltrexone Prodrugs for Transdermal Delivery$253,400
R01 · FY2003 · DA
Naltrexone Prodrugs for Transdermal Delivery$253,400
R01 · FY2002 · DA